• Applications & Products
    • Applications
    • Products
  • Media Formulation
  • About InVitria
  • News & Blog
  • Contact Us
  • Terms
  • Privacy
  • Sitemap
Performance. Defined.
  • 1-800-916-8311 or Email Us
  • iconMy Account
  • iconView Cart
  • Applications & Products
    • Applications
      • Gene Therapy
      • Cell Therapy
      • T-Cell Immunotherapy
      • Vaccine Production
      • Antibody Production
      • Final Formulation
      • Food Science
    • Product Types
      • Blood-Free Cell Culture Media
      • Cell Culture Components
      • Insulin-Transferrin Supplements
      • Recombinant Albumin
      • Recombinant Transferrin
      • Recombinant Human Lysozyme
      • Recombinant Human Interleukins
    • Products
      • Cellastim S® – Recombinant human albumin
      • Exbumin® – Recombinant human albumin excipient
      • Optibumin® 20 – Recombinant human albumin
      • Optibumin® 25 – Recombinant human albumin
      • Optiferrin® – Recombinant human transferrin
      • Lacromin® – Recombinant human holo lactoferrin
      • ITS AF – Blood-free cell culture media supplement
      • ITSE + A – Blood-free cell culture media supplement
      • ITSE Animal-Free® – Blood-free cell culture media supplement
      • Lysobac® – Recombinant human lysozyme
      • OptiLeukin 2 – Recombinant human IL-2
      • LIF – Leukemia Inhibitory Factor
      • OptiVERO® – Chemically-defined complete VERO media
  • About InVitria
  • News & Blog
  • Contact Us
  • Knowledge Base
  • Applications
  • Products
  • Contact Us
  • Home
  • ITS-Animal-Free™ Supplementation for iPSC Expansion and Pluripotency: A Platform Approach for Serum-Free Cell Expansion

ITS-Animal-Free™ Supplementation for iPSC Expansion and Pluripotency: A Platform Approach for Serum-Free Cell Expansion

Published on 26 June 2025

Application Note

Authors: Mark Stathos, PhD & Andrew Hamann, PhD
InVitria, Inc., USA

Overview

This application note evaluates the use of ITS Animal-Free™ (ITS AF)—a recombinant, animal-origin-free supplement containing insulin, transferrin, and selenium—for serum-free expansion of human induced pluripotent stem cells (iPSCs). The study demonstrates that ITS AF supports robust iPSC proliferation and maintains high levels of Oct4, Sox2, and Nanog expression, performing comparably to a leading competitor at all tested concentrations without requiring media optimization.

Key Findings

  • Enables robust iPSC proliferation in serum-free systems
  • Maintains ≥85% Oct4+/Sox2+/Nanog+ pluripotent population
  • Matches performance of competitor ITS across all doses
  • Pre-optimized, animal-origin-free formulation simplifies media development

Materials & Methods

Human iPSCs maintained in Essential 8™ media (ThermoFisher Scientific) were dissociated using Accutase® (ThermoFisher Scientific) and seeded into 96-well plates at 10,000 cells per well. Each well was coated with 0.5 µg/cm² N-terminal truncated Vitronectin™ (ThermoFisher Scientific) and supplemented with 10 µM Y-27632 ROCK inhibitor.

Cells were cultured in one of the following conditions:

  • E5 media (homemade Essential 8 without ITS)
  • E5 supplemented with 1–5x InVitria ITS AF™ or competitor ITS
  • Complete commercial Essential 8

Plates were incubated on an Incucyte SX5 system (Sartorius), and proliferation was monitored via confluence measurements taken every 2 hours. After 24 hours, the media was changed to remove ROCK inhibitor, and monitoring continued for an additional 24 hours.

At 48 hours, cells were harvested using Accutase® and stained for flow cytometry.

  • Viability was assessed using Zombie Aqua™ fixable dye (BioLegend).
  • Cells were fixed and permeabilized with the FOXP3 eBioscience™ buffer set (ThermoFisher Scientific).
  • Cells were stained with pluripotency markers:
    • Oct4 Alexa Fluor® 647
    • Sox2 Alexa Fluor 488
    • Nanog Alexa Fluor 594 (BioLegend antibody catalog)

Samples were analyzed using a CytoFLEX LX™ flow cytometer (Beckman Coulter).
Pluripotency was defined as the percentage of live cells triple-positive for Oct4, Sox2, and Nanog.

Featured Solution

 

ITS Animal-Free Blood-free cell culture media supplement, three bottles

ITS Animal-Free – Recombinant Insulin, Transferrin, and Selenium Supplement

ITS Animal-Free™ (ITS AF) is a chemically defined, animal-origin-free 100x liquid supplement designed to replace serum in cell culture. It supports robust proliferation and maintains pluripotency in iPSCs and other mammalian cell types. ITS AF eliminates the variability and regulatory concerns associated with serum-derived inputs, enabling more consistent, compliant, and scalable workflows in cell and gene therapy, regenerative medicine, and vaccine development.

Learn more about ITS AF

Download the Application Note

First page of application note showing ITS AF™ benefits for iPSC expansion and pluripotency with graphs comparing InVitria and competitor ITS performance
Explore the data: Download the full ITS AF™ Application Note to see how this animal-origin-free supplement supports iPSC expansion and pluripotency.
View PDF Here

Footnotes

References

  • Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676. https://doi.org/10.1016/j.cell.2006.07.024

  • Villa-Diaz, L. G., Ross, A. M., Lahann, J., & Krebsbach, P. H. (2013). Concise review: The evolution of human pluripotent stem cell culture: From feeder cells to synthetic coatings. Stem Cells, 31(1), 1–7. https://doi.org/10.1002/stem.1190

  • Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147. https://doi.org/10.1126/science.282.5391.1145

  • Li, P., Wang, S., Zhan, L., He, X., Chi, G., Lv, S., Xu, Z., Xia, Y., Teng, S., Li, L., & Li, Y. (2017). Efficient feeder cells preparation system for large-scale preparation and application of induced pluripotent stem cells. Scientific Reports, 7, 12266. https://doi.org/10.1038/s41598-017-10428-5

  • Lyra-Leite, D. M., Gutiérrez-Gutiérrez, Ó., Wang, M., Zhou, Y., Cyganek, L., & Burridge, P. W. (2022). A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming. STAR Protocols, 3(3), 101560. https://doi.org/10.1016/j.xpro.2022.101560

  • Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M., Ruotti, V., Probasco, M. D., Smuga-Otto, K., Howden, S. E., Diol, N. R., Propson, N. E., & Thomson, J. A. (2011). Chemically defined conditions for human iPSC derivation and culture. Nature Methods, 8(5), 424–429. https://doi.org/10.1038/nmeth.1593

  • Guilbert, L. J., & Iscove, N. N. (1976). Partial replacement of serum by transferrin, albumin and lecithin in haemopoietic cell cultures. Nature, 263(5574), 594–595. https://doi.org/10.1038/263594a0

  • Barnes, D., & Sato, G. (1980). Serum-free cell culture: A unifying approach. Cell, 22(3), 649–655. https://doi.org/10.1016/0092-8674(80)90540-1

  • Straus, D. S. (1981). Effects of insulin on cellular growth and proliferation. Life Sciences, 29(21), 2131–2139. https://doi.org/10.1016/0024-3205(81)90482-3

  • Luck, A. N., & Mason, A. B. (2012). Transferrin-mediated cellular iron delivery. Current Topics in Membranes, 69, 3–35. https://doi.org/10.1016/B978-0-12-394390-3.00001-X

  • Laskey, J., Webb, I., Schulman, H. M., & Ponka, P. (1988). Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis. Experimental Cell Research, 176(1), 87–95. https://doi.org/10.1016/0014-4827(88)90123-1

  • Zeng, H. (2009). Selenium as an essential micronutrient: Roles in cell cycle and apoptosis. Molecules, 14(3), 1263–1278. https://doi.org/10.3390/molecules14031263

  • Rodda, D. J., Chew, J. L., Lim, L. H., Loh, Y. H., Wang, B., Ng, H. H., & Robson, P. (2005). Transcriptional regulation of Nanog by OCT4 and SOX2. Journal of Biological Chemistry, 280(26), 24731–24737. https://doi.org/10.1074/jbc.M502573200

  • Han, Z., Yu, Y., Xu, J., Bao, Z., Xu, Z., Hu, J., Yu, M., Bamba, D., Ma, W., Ding, F., Zhang, L., Jin, M., Yan, G., Huang, Q., Wang, X., Hua, B., Yang, F., Li, Y., Lei, L., … Cai, B. (2019). Iron homeostasis determines fate of human pluripotent stem cells via glycerophospholipids-epigenetic circuit. Stem Cells, 37(4), 489–503. https://doi.org/10.1002/stem.2967

Start New Search

Quick Search Links

Application:

Antibody Production

Cell Therapy

Final Formulation

Food Science

Gene Therapy

T-Cell Immunotherapy

Vaccine Production

Product Category:

Cell Culture Supplements

Albumin

Cell Culture Media

Interleukins

Lactoferrin

LIF

Lysozyme

Single Components

Transferrin

Product:

Exbumin® – Recombinant human albumin excipient

ITS AF™ – Blood-free cell culture media supplement

ITSE + A™ – Blood-free cell culture media supplement

ITSE Animal-Free® – Blood-free cell culture media supplement

Lacromin® – Recombinant human holo-lactoferrin

OptiLeukin™ 2 – Recombinant human interleukin-2

OptiVERO®

Cellastim® S – Recombinant human albumin

Optibumin ® 20 – Recombinant human albumin

Optibumin ® 25 – Recombinant human albumin

Optiferrin® – Recombinant human transferrin

Leukemia Inhibitory Factor

Lysobac® – Recombinant human lysozyme

Document Type:

Application Notes

Blog

Catalog

Data Sheets

Interviews

Journal Articles (DOI Links)

News

Posters

Product Brochures

Product Specifications

SDS

Use Guidelines

Webinar

White Papers

Cell Line:

B Lymphocyte

CHO

ESC

HEK293

Hematopoetic Stem Cells

Hybridoma

iPSC

Mesenchymal Stem Cells

Natural Killer Cells

Neural Stem Cells

T Lymphocyte

VERO

  • 2718 Industrial Drive • Junction City, KS 66441
  • 800-916-8311
  • © 2025 InVitria

    • Terms
    • Privacy
    • Sitemap